Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid cancer from high risk thyroid cancer. However, recent studies have questioned both the precise 45 year age point and the concept of using a binary cut off as accurate predictors of disease specific mortali...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thyroid (New York, N.Y.) N.Y.), 2015-10, Vol.25 (10), p.116-1114
Hauptverfasser:	Ganly, Ian, Nixon, Iain J., Wang, Laura Y., Palmer, Frank L., Migliacci, Jocelyn C., Aniss, Ahmad, Sywak, Mark, Eskander, Antoine E., Freeman, Jeremy L., Campbell, Michael J., Shen, Wen T., Vaisman, Fernanda, Momesso, Denise, Corbo, Rossana, Vaisman, Mario, Shaha, Ashok, Tuttle, R. Michael, Shah, Jatin P., Patel, Snehal G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - mortality Adenocarcinoma - pathology Adult Age Factors Age of Onset Aged Aged, 80 and over Female Humans Male Middle Aged Neoplasm Staging Nomograms Prognosis Survival Rate Thyroid Cancer and Nodules Thyroid Neoplasms - mortality Thyroid Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!